Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Asset disposition Quarterly results Departure of a VP CC transcript
|
CONCEPTUS INC (CPTS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/29/2013 |
8-K
| Quarterly results
Docs:
|
"Agreement and Plan of Merger, by and among Conceptus, Inc., Bayer HealthCare LLC and Evelyn Acquisition Company",
"Bayer HealthCare to Acquire Conceptus ® MOUNTAIN VIEW, Calif. and LEVERKUSEN, Germany, April 29, 2013 — Conceptus, Inc. , developer of the Essure ® procedure, the leading surgery-free permanent birth control method, announced today that Conceptus has signed a definitive merger agreement with Bayer HealthCare LLC, Leverkusen, Germany. With this acquisition, Bayer will be able to offer a complete range of short-term, long-term and permanent contraceptive choices for women. Within the next ten business days, Bayer will launch a public tender offer to acquire all shares of common stock of Conceptus, Inc. The transaction values Conceptus, Inc. at approx. US$1.1 billion representing US$31.00 per share in cash. Closing is subject to customary conditions, in particular anti-trust approval in the U...",
"Conceptus ® Reports First Quarter Financial Results" |
|
10/23/2012 |
8-K
| Quarterly results |
07/31/2012 |
8-K
| Quarterly results |
04/26/2012 |
8-K
| Quarterly results |
02/23/2012 |
8-K
| Quarterly results |
10/25/2011 |
8-K
| Form 8-K - Current report |
05/10/2011 |
8-K
| Quarterly results |
02/24/2011 |
8-K
| Form 8-K - Current report |
10/28/2010 |
8-K
| Form 8-K - Current report |
10/29/2008 |
8-K
| Quarterly results |
02/19/2008 |
8-K
| Quarterly results |
04/30/2007 |
8-K
| Quarterly results |
02/27/2007 |
8-K
| Quarterly results |
02/06/2007 |
8-K
| Asset disposition, Quarterly results |
08/09/2006 |
8-K
| Quarterly results, Conference call transcript
Docs:
|
"Conceptus Reports Record $10 Million Second Quarter Net Sales Tuesday July 25, 4:02 pm ET Sets new highs for physician training Increases 2006 guidance MOUNTAIN VIEW, Calif.——July 25, 2006—Conceptus, Inc. , developer of the Essure® non-incisional permanent birth control system, today reported financial results for the three and six months ended June 30, 2006. Net sales for the second quarter of 2006 were $10.0 million, up 99% over net sales of $5.0 million for the second quarter of 2005 and up 26% over net sales of $8.0 million for the first quarter of 2006. These results exceeded the Company's guidance for second quarter 2006 net sales of $9.0 million. The net loss for the second quarter of 2006 was $5.3 million, or $0.18 per share, including charges of $1.6 million, or $0.05 per share, f...",
"Transcript of conference call held on July 25, 2006" |
|
04/26/2006 |
8-K
| Quarterly results |
02/15/2006 |
8-K
| Quarterly results |
07/27/2005 |
8-K
| Quarterly results |
07/14/2005 |
8-K
| Quarterly results |
11/08/2004 |
8-K
| Quarterly results |
07/30/2004 |
8-K
| Quarterly results |
04/22/2004 |
8-K
| Quarterly results |
10/30/2003 |
8-K
| Quarterly results |
|
|